In the mouse PC, H3K4me3 has been implicated in promoting pancreatic tumor growth and progression through the activation of the osteopontin (OPN)-CD44 axis, which in turn promotes immune evasion in pancreatic cancer [154]. The gene discussed is CD44; the disease is pancreatic neoplasm.